News from neurogesx A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 29, 2011, 07:00 ET NeurogesX CEO Anthony DiTonno to Retire by Year End

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Apr 28, 2011, 08:00 ET NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Nov 02, 2010, 09:00 ET NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Oct 28, 2010, 09:00 ET NeurogesX to Present at Oppenheimer & Co Healthcare Conference

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced...


Oct 28, 2010, 08:30 ET NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Oct 18, 2010, 09:00 ET NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Aug 05, 2010, 04:02 ET NeurogesX Announces Proposed Shelf Registration Statement

NeurogesX, Inc. (Nasdaq: NGSX) announced today that on or about the filing date of its upcoming Quarterly Report on Form 10-Q for the quarter ended...


Jul 30, 2010, 08:30 ET NeurogesX to Hold Conference Call to Discuss Second Quarter 2010 Results

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Jun 03, 2010, 09:00 ET NeurogesX to Present at Two Upcoming Conferences

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced...


May 04, 2010, 06:43 ET NeurogesX to Hold Conference Call to Discuss First Quarter 2010 Results

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...


Mar 18, 2010, 04:00 ET NeurogesX Reports Fourth Quarter and Year-End 2009 Results

2009 Corporate Highlights: Received U.S. Food and Drug Administration (FDA) approval of Qutenza® (capsaicin) 8% patch for management of neuropathic...


Mar 12, 2010, 09:00 ET NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2009 Results

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today...